<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-Y9MKKSSJ/ebc51522-ec39-467d-b854-1ce52c7ade02/PDF"><dcterms:extent>184 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-Y9MKKSSJ/9da8ec32-f210-4148-9c8f-190c922c9984/TEXT"><dcterms:extent>48 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-Y9MKKSSJ"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>2009</dcterms:issued><dc:creator>Lunder, Mojca</dc:creator><dc:creator>Žiberna, Lovro</dc:creator><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">letnik:48</dc:format><dc:format xml:lang="sl">str. 339-351</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:26481113</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-Y9MKKSSJ</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="en">Alcohol, Ethyl</dc:subject><dc:subject xml:lang="sl">ateroskleroza</dc:subject><dc:subject xml:lang="en">Atherosclerosis</dc:subject><dc:subject xml:lang="sl">Dušikov oksid</dc:subject><dc:subject xml:lang="sl">Fenoli</dc:subject><dc:subject xml:lang="en">Flavones</dc:subject><dc:subject xml:lang="sl">Flavoni</dc:subject><dc:subject xml:lang="en">Inflammation</dc:subject><dc:subject xml:lang="sl">Lipoproteini nizke gostote</dc:subject><dc:subject xml:lang="sl">Lipoproteini visoke gostote</dc:subject><dc:subject xml:lang="en">Lipoproteins, Hdl</dc:subject><dc:subject xml:lang="en">Lipoproteins, Ldl</dc:subject><dc:subject xml:lang="sl">Mišica gladka</dc:subject><dc:subject xml:lang="en">Muscle, Smooth</dc:subject><dc:subject xml:lang="en">Nitric Oxide</dc:subject><dc:subject xml:lang="en">Phenols</dc:subject><dc:subject xml:lang="en">Platelet Aggregation</dc:subject><dc:subject xml:lang="sl">polifenoli</dc:subject><dc:subject xml:lang="en">Prevention And Control</dc:subject><dc:subject xml:lang="sl">preventiva</dc:subject><dc:subject xml:lang="sl">Trombociti, agregacija</dc:subject><dc:subject xml:lang="sl">Vino</dc:subject><dc:subject xml:lang="sl">Vnetje</dc:subject><dc:subject xml:lang="en">Wine</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q5508498" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Mehanizmi zaščitnega delovanja rdečega vina pri preprečevanju razvoja ateroskleroze| Beneficial effects of red wine in preventing the development of atherosclerosis|</dc:title><dc:description xml:lang="sl">Numerous predinical and dinical studies have shown a correlation between the consumption of moderate amounts of red wine and a reduced risk of cardiovascular complications associated with atherosderosis. Both polyphenoliccomponents and ethanol are responsible for the apparent protectiveeffects of red wine, as they influence different biochemical and cellular processes and thus affect the development and progression of atherosderosis. The polyphenolic compounds of red wine reduce the endothelial dysfunction and thus improve the endothelial function, prevent the oxidation oflow-density lipoproteins (LDL), attenuate proliferation and migration of smooth musde cells, inhibit platelet aggregation and adhesion and also reduce the serum concentration of inflammatory mediators. Ethanol, similarly to polyphenolic compounds of red wine, inhibits platelet aggregation and adhesion, but also increases the levels of high-density lipoproteins (HDL). The present paper describes the main pharmacologically active compounds of redwine and their impact on various processes in the progression and development of atherosderosis</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-Y9MKKSSJ"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-Y9MKKSSJ" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-Y9MKKSSJ/ebc51522-ec39-467d-b854-1ce52c7ade02/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-Y9MKKSSJ/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-Y9MKKSSJ" /></ore:Aggregation></rdf:RDF>